STOCK TITAN

CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company, announced that it will release its first quarter 2022 financial results on May 12, 2022, after market close. A conference call and webcast will follow at 4:30 p.m. EDT to discuss these results with analysts and investors. Key management, including CEO Dwight Egan and CFO Brian Brown, will participate in the call. The call will be accessible via the company's website and will also be recorded for later viewing.

Positive
  • None.
Negative
  • None.

SALT LAKE CITY, April 28, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2022 results on Thursday, May 12, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors.  Management on the call will include Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations.

The call and webcast will be available via:

Webcast:                 

ir.codiagnostics.com on the Events & Webcasts page

Conference Call:       

877-317-6789 (domestic) or 412-317-6789 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures, and markets state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-first-quarter-2022-earnings-release-date-and-webcast-301535166.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics, Inc. release its Q1 2022 earnings?

Co-Diagnostics, Inc. will release its Q1 2022 earnings on May 12, 2022, after market close.

What time is the Co-Diagnostics Q1 2022 earnings call?

The Co-Diagnostics Q1 2022 earnings call is scheduled for 4:30 p.m. EDT on May 12, 2022.

Who will present during the Co-Diagnostics earnings call?

The earnings call will feature CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson.

How can I listen to the Co-Diagnostics earnings call?

You can listen to the Co-Diagnostics earnings call via their website or by calling 877-317-6789 (domestic) or 412-317-6789 (international).

Will the Co-Diagnostics earnings call be available later?

Yes, if you cannot attend the live webcast, it will be recorded and made available on the company's website.

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

23.60M
29.79M
6.7%
13.96%
0.72%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY